β-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E:: Relevance to Alzheimer's disease

被引:79
作者
Pillot, T
Goethals, M
Najib, J
Labeur, C
Lins, L
Chambaz, J
Brasseur, R
Vandekerckhove, J
Rosseneu, M
机构
[1] Inst Biomed Cordeliers, INSERM, CJF 9508, F-75006 Paris, France
[2] Univ Ghent, Lab Lipoprot Chem, Fac Med, B-9000 Ghent, Belgium
[3] State Univ Ghent VIB, Dept Biochem, Fac Med, B-9000 Ghent, Belgium
[4] Fac Sci Agron Etat Gembloux, Ctr Biophys Mol Numer, Gembloux, Belgium
[5] Fac Pharm Lille, Lille, France
关键词
apolipoprotein E; beta-amyloid peptide; peptide/peptide interaction; Alzheimer's disease;
D O I
10.1046/j.1471-4159.1999.0720230.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence indicates the involvement of apolipoprotein E (apoE) in the development of late-onset and sporadic forms of Alzheimer's disease, although its exact role remains unclear. We previously demonstrated that beta-amyloid peptide (A beta) displays membrane-destabilizing properties and that only apoE2 and E3 isoforms inhibit these properties. In this study, we clearly demonstrate that the carboxy-terminal lipid-binding domain of apoE (e.g., residues 200-299) is responsible for the A beta-binding activity of apoE and that this interaction involves pairs of apoE amphipathic alpha-helices. We further demonstrate that A beta is able to inhibit the association of the C-terminal domain of apoE with lipids due to the formation of A beta/apoE complexes resistant to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. On the contrary, the amino-terminal receptor-binding domain of apoE (e.g,, residues 129-169) is not able to form stable complexes with A beta. These data extend our understanding of human apoE-dependent binding of A beta by involving the C-terminal domain of apoE in the efficient formation of apoE/A beta complex.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 41 条
[1]  
AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
[2]   Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease affected brains: a possible role for apolipoprotein E in Alzheimer's disease [J].
Aizawa, Y ;
Fukatsu, R ;
Takamaru, Y ;
Tsuzuki, K ;
Chiba, H ;
Kobayashi, K ;
Fujii, N ;
Takahata, N .
BRAIN RESEARCH, 1997, 768 (1-2) :208-214
[3]   Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease [J].
Aleshkov, S ;
Abraham, CR ;
Zannis, VI .
BIOCHEMISTRY, 1997, 36 (34) :10571-10580
[4]   Peptides in membranes: Tipping the balance of membrane stability [J].
Brasseur, R ;
Pillot, T ;
Lins, L ;
Vandekerckhove, J ;
Rosseneu, M .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (05) :167-171
[5]   SYNTHETIC MODEL PEPTIDES FOR APOLIPOPROTEINS .1. DESIGN AND PROPERTIES OF SYNTHETIC MODEL PEPTIDES FOR THE AMPHIPATHIC HELICES OF THE PLASMA APOLIPOPROTEINS [J].
BRASSEUR, R ;
VANLOO, B ;
DELEYS, R ;
LINS, L ;
LABEUR, C ;
TAVEIRNE, J ;
RUYSSCHAERT, JM ;
ROSSENEU, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1170 (01) :1-7
[6]   APOLIPOPROTEIN-E CARBOXYL-TERMINAL FRAGMENTS ARE COMPLEXED TO AMYLOID-A AND AMYLOID-L - IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMERS-DISEASE [J].
CASTANO, EM ;
PRELLI, F ;
PRAS, M ;
FRANGIONE, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17610-17615
[7]   FIBRILLOGENESIS IN ALZHEIMERS-DISEASE OF AMYLOID-BETA PEPTIDES AND APOLIPOPROTEIN-E [J].
CASTANO, EM ;
PRELLI, F ;
WISNIEWSKI, T ;
GOLABEK, A ;
KUMAR, RA ;
SOTO, C ;
FRANGIONE, B .
BIOCHEMICAL JOURNAL, 1995, 306 :599-604
[8]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[9]   COMPARISON OF LIPID-BINDING AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVATION OF THE AMINO-TERMINAL AND CARBOXYL-TERMINAL DOMAINS OF HUMAN APOLIPOPROTEIN E3 [J].
DEPAUW, M ;
VANLOO, B ;
WEISGRABER, K ;
ROSSENEU, M .
BIOCHEMISTRY, 1995, 34 (34) :10953-10960
[10]  
DONG LM, 1994, J BIOL CHEM, V269, P22358